# IMMUNE PHARMACEUTICALS INC — Form D

IMMUNE PHARMACEUTICALS INC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-14. The offering totals $11.7M, of which $11.7M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2014-04-14
- Form: D
- Accession: 0001208261-14-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $11.7M
- Amount sold: $11.7M
- Investors: 42
- Date of first sale: 2014-03-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-215479

## Issuer

- Name: IMMUNE PHARMACEUTICALS INC
- CIK: 0001208261
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 708 THIRD AVENUE, NEW YORK, NY, 10017
- Phone: 914-606-3500

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Daniel G Kazado | Director | New York, NY |
| Isaac G Kobrin | Director | New York, NY |
| Rene G Lerer | Director | New York, NY |
| David G Sidransky | Director | New York, NY |
| Ana G Stancic | Director | New York, NY |
| Daniel G Teper | Director | New York, NY |
| Daniel G Teper | Executive Officer | New York, NY |

## More

- [CIK 1208261 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1208261&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001208261-14-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.